News | Clinical Study | June 28, 2016

Two U.K. Studies Validate Weekend Effect Among Heart Patients

Data suggests weekend discharge and admission from hospital affects people with certain heart conditions

U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure

June 28, 2016 — New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial fibrillation or heart failure over the weekend face a higher risk of dying over the next five years than those admitted during normal hours. The research, led by Rahul Potluri, M.D., founder of the ACALM study unit at Aston University, was presented at the British Cardiovascular Society (BCS) Conference, June 6-8 in Manchester.

The study of 42,687 patients with AF, one of the most common forms of abnormal heart rhythm, finds that those admitted outside of normal operating hours (9 a.m.-5 p.m., Monday-Friday) have a 10 percent increased risk of dying in the next five years. The research was adjusted to account for external factors that could influence death rates such as age, gender, ethnic group and the most common causes of mortality in the U.K.

Normally, the heart’s natural pacemaker sends out a regular electrical impulse that travels through the heart. But when someone has AF, impulses fire off from different places in the atria, causing chaotic electrical activity, which makes them have an irregular and sometimes fast pulse. AF affects about one million people in the U.K. – or 1.7 percent of the population – but many more are undiagnosed and do not know they have it.

In a separate study, the researchers also looked at 31,760 heart failure patients discharged from hospitals in the north of England on weekends, finding a 32 percent increased chance of dying over the next five years compared to those sent home during regular weekday hours.

Across the U.K. there are more than 500,000 people diagnosed with heart failure.

Heart failure is a disabling condition and severe heart failure can have a worse life expectancy than many cancers. It is most commonly caused following a heart attack when the heart muscle suffers irreparable damage and can no longer pump blood efficiently around the body. In severe cases people with heart failure are left unable to perform regular day-to-day activities like walking upstairs or are left breathless even when resting. Up to a third of patients admitted to the hospital with heart failure will die within twelve months.

Potluri said, “This study shows that the weekend effect is very much a reality for those suffering two of the most prevalent heart conditions in the U.K. These patients are, quite simply, more likely to die if admitted or discharged outside regular hours, and that trend is particularly noticeable at the weekend.

Paul Carter, M.D., presenting author at the BCS Conference, said: “We took steps during this study to ensure that the comparison between the two groups was as fair as possible.

“It is interesting that both being admitted or discharged from hospital on the weekend confers an increased risk, and one which is sustained in the long-term. We cannot comment on the underlying reasons for this from our study but it suggests that the level of support provided at weekends, from all teams involved in healthcare — in the hospital and in the community — should be addressed.”

Potluri added, “What this research shows is that the weekend effect is not a universal phenomenon. Across the two conditions we studied, its impact was varied, suggesting it can’t be tackled effectively by blanket improvements to care.

“Further research is urgently needed to assess what the implications of the weekend effect are for individual conditions, before any costly changes to services are implemented.”

Read the related article about a similar U.S. study, "Day of the Week PCI-Related Hospitalization Occurs Determines Likelihood of Survival."

For more information: www.bcs.com/conference

Related Content

Boston Scientific's Apama multi-electrode ablation balloon to treat atrial fibrillation.

Boston Scientific's Apama multi-electrode ablation balloon to treat atrial fibrillation. The technology allows different energies to be used for each electrode to prevent damage to the esophagus or other underlying critical structures. 

Feature | Atrial Fibrillation | January 15, 2018 | Dave Fornell
The development of atrial fibrillation (AFib or AF) ablation technologies over the past 20 years has been a constant
Heart Rhythm Society Partners With WebMD Education to Increase Atrial Fibrillation Awareness
News | Atrial Fibrillation | January 02, 2018
The Heart Rhythm Society (HRS), in partnership with WebMD Education, announced in December the launch of a free, online...
The Boston Scientific Rhythmia Mapping System produces higher-density voltage maps without increasing overall procedure time.

The Boston Scientific Rhythmia Mapping System produces higher-density voltage maps without increasing overall procedure time. It was the first of a new generation of high-density mapping systems to be introduced.

Feature | Atrial Fibrillation | December 18, 2017 | Kenneth Stein, M.D. FACC FHRS
When I began practicing as an electrophysiologist in 1994, the dream of successfully using cardiac catheter ablation
Acutus dipole density EP mapping for ablation procedures.

The FDA recently cleared high-speed Acutus Medical's AcQMap High Resolution image and mapping system and the AcQMap 3-D Imaging and Mapping Catheter.  detects and displays both standard voltage-based and higher resolution dipole density (charge-source) maps. The system combines ultrasound anatomy construction with an ability to map the electrical-conduction of each heartbeat to identify complex arrhythmias across the entire atrial chamber. Following each ablation treatment, the heart can be re-mapped in seconds to continually visualize any changes from the prior mapping.

 

 

Feature | Atrial Fibrillation | November 07, 2017
November 7, 2017 — Here is an aggregated list of articles detailing the latest clinical data and new device technolog
The Watchman LAA occluder PREVAIL Trial 5-year results were presented at the 2017 TCT meeting.
Feature | Atrial Fibrillation | November 02, 2017
November 2, 2017 – Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the B
UNC School of Medicine Receives $1.7 Million for Atrial Fibrillation Program Streamlining Patient Care
News | Atrial Fibrillation | October 23, 2017
October 23, 2017 — University of North Carolina (UNC) School of Medicine cardiologist Anil Gehi, M.D., will use a $1.
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation | September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation | September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Overlay Init